Related Experiment Video
Updated: Sep 23, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Structural analysis of the primary specificity of thrombin
Tristan Friet1, George Mikhail1, Bassem M Mohammed1
1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104 USA.
Background:
Thrombin has dual trypsin-like and chymotrypsin-like specificity: it prefers substrates carrying Arg at the site of cleavage (P1) in the activation peptide because of the presence of D189 in the primary specificity (S1) site but can also cleave substrates carrying Phe at P1.
Objective:
Explore the structural basis of the P1-S1 interaction with mutants of D189 and substrates carrying different residues at P1.
Methods:
X-ray crystallography is used to solve the structures of thrombin wild-type and mutants D189A, D189F and D189K bound to the irreversible inhibitors H-D-Phe-Pro-Arg-CH2Cl (FPRck), H-D-Phe-Pro-Phe-CH2Cl (FPFck) and H-D-Phe-Pro-Gln-CH2Cl (FPQck).
Results:
X-ray structures of thrombin wild-type and mutants D189A, D189F and D189K bound to FPRck, FPFck and FPQck are solved at high resolutions, from 1.2 Å to 2.5 Å. Mutations of D189 do not affect stability of free thrombin but shift the substrate preference from Arg to Phe at P1 and the stability of the inhibited complex from FPRck to FPFck. The structures reveal the flexibility of the S1 site in accommodating side chains of different chemical properties to optimize the P1-S1 interaction. In the D189K-FPRck complex, the inhibitor is trapped in an intermediate state covalently bound only to the catalytic H57 and with the Arg side chain positioned outside of the active site.
Conclusions:
The S1 site of thrombin features unexpected structural flexibility and can withstand the replacement of D189 with Ala, Phe or even Lys. The results set the stage for future studies aimed at re-engineering primary specificity in thrombin and other trypsin-like proteases.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions
Some...
Venous Thrombosis I: Introduction
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Protein Folding

